SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-04-014858
Filing Date
2004-05-17
Accepted
2004-05-17 16:32:39
Documents
9
Period of Report
2004-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a04-4680_110q.htm 10-Q 700628
2 EX-10.33 a04-4680_1ex10d33.htm EX-10.33 36374
3 EX-10.34 a04-4680_1ex10d34.htm EX-10.34 2150
4 EX-10.35 a04-4680_1ex10d35.htm EX-10.35 231700
5 EX-10.36 a04-4680_1ex10d36.htm EX-10.36 55103
6 EX-31.1 a04-4680_1ex31d1.htm EX-31.1 8510
7 EX-31.2 a04-4680_1ex31d2.htm EX-31.2 8564
8 EX-32.1 a04-4680_1ex32d1.htm EX-32.1 5832
9 EX-32.2 a04-4680_1ex32d2.htm EX-32.2 6119
  Complete submission text file 0001104659-04-014858.txt   1057394
Mailing Address 375 WEST ST WEST BRIDGEWATER MA 02379
Business Address 375 WEST STREET WEST BRIDGEWATER MA 02379 5085801900
BOSTON BIOMEDICA INC (Filer) CIK: 0000830656 (see all company filings)

IRS No.: 042652826 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21615 | Film No.: 04812891
SIC: 2835 In Vitro & In Vivo Diagnostic Substances